Why does the hair cycle shorten? Reading the timeline of follicle miniaturization behind thinning hair, and how stem cell conditioned media fits in2026.07.11
“My hair has gotten finer.” “I can see my scalp through it now.” When you first notice these signs, what is actually happening on your scalp? Thinning hair rarely starts overnight — it is the accumulated result of a hair cycle that gradually shortens and a change called follicle miniaturization, which finally reveals itself in the mirror as reduced density. In this article, Dr. Moriwaki of AVAN TOKYO Ginza explains the timeline over which this shrinking process unfolds, and how stem cell conditioned media may fit into that process.
Key Points of This Article
・A shortened anagen phase combined with follicle miniaturization is why thinning hair emerges as a “product of time.”
・When the anagen phase shortens, the same follicle can only produce a thinner and shorter hair.
・Variation in hair caliber and a drop to single-hair units are early signs that can be objectively observed under a microscope.
・Stem cell conditioned media is expected to act on the microenvironment of the dermal papilla and may work as a supportive approach to slow progression.
・Intervening while the change is still “a hint” rather than obvious is the fastest strategy to keep time on your side.
What Is the Hair Cycle — Anagen, Catagen, and Telogen
The length of anagen decides “how thick and how long” hair grows
A healthy scalp hair cycle consists of three phases: anagen (growth) 2–6 years, catagen (regression) 2–3 weeks, and telogen (resting) about 3 months. That 80–90% of scalp hairs are in anagen at any given time is the biochemical basis for a full head of hair.
The longer anagen lasts, the thicker and longer the hair grows. Conversely, if anagen shortens, even the same follicle can only produce thinner, shorter shafts. This “loss of time” is the entry point of the follicle-shrinking process.
Catagen and telogen — the “switching time”
In catagen, the hair bulb involutes through apoptosis, and after telogen the follicle transitions to the next anagen. When telogen lengthens, the lag before a new hair sprouts from the vacated follicle extends, and visible “density” drops. Each phase of the hair cycle is precisely regulated by hormones, growth factors, and the local inflammatory state — and when that balance breaks down, it triggers the shrinking process.
Why Does the Hair Cycle Shorten — The Mechanism of the Shrinking Change
Androgen signaling and changes in the dermal papilla response
The central mechanism of androgenetic alopecia (AGA) is that testosterone is converted by 5α-reductase into dihydrotestosterone (DHT), which acts through androgen receptors in dermal papilla cells to send an anagen-shortening signal. As a result, growth-inhibiting factors such as TGF-β1 and DKK-1 rise, and follicles in anagen switch prematurely into catagen.
In female pattern hair loss (FAGA), the same pathway contributes, but with the added complexity of a relative decline in estrogen with age and changes in dermal papilla sensitivity to signals. Both push the “clock that keeps the hair cycle” faster, accelerating follicle miniaturization.
The temporal shift — a shorter anagen and a longer telogen
As the hair cycle shortens, anagen contracts from years toward months, while telogen tends to extend. When this two-way temporal shift occurs, the proportion of anagen hairs per unit area declines, and the share of telogen hairs and empty follicles increases. If this state continues, the follicles themselves shrink, and the diameter of the hair they produce can decrease to around 0.06 mm.
The Timeline From Follicle Shrinkage to “Visible Thinning”
Caliber thinning that develops over 1–3 years
The first change in the shrinking process is not a drop in hair count but variation in hair caliber. Under a microscope, you can see thick hairs and fine hairs coexisting from the same follicle — a finding known as anisotrichosis. At this stage, subjective symptoms are subtle and often stop at “my hair just feels softer than before.”
The number of hairs per follicular unit also trends downward, moving toward single hairs from areas that would normally show 2–3 hairs. Over a comparatively short span of 1–3 years, these microscopic changes accumulate.
Reduction in hair count that unfolds over years to a decade
After caliber thinning and single-hair conversion continue, the “visibly thin” stage arrives. By the time someone becomes aware that “my scalp shows through” or “my hair won’t hold a style,” follicle miniaturization has often already been progressing for years. Read the other way around, if you start caring for the scalp environment while the caliber variation is still just a hint, you may buy time before visible density loss arrives. This is the medical significance of early intervention.
How stem cell conditioned media may relate to follicle miniaturization
What the growth factor cocktail delivers to the dermal papilla
Stem cell conditioned media contains multiple growth factors — VEGF, IGF-1, HGF, KGF, FGF and others — that relate to dermal papilla cell proliferation and perifollicular angiogenesis. At the basic-research level, these secreted factors have been suggested to help maintain anagen follicles and support the telogen-to-anagen transition.
That said, stem cell conditioned media is not a magic that “reverses” the shrinking of follicles. The honest framing is to combine it with existing oral and topical treatment as a supportive approach that shapes the microenvironment of the dermal papilla. Response varies between individuals, and what can be expected depends on the stage of progression.
The medical meaning of “acting early”
The follicle-shrinking process includes some irreversible changes, but as long as the follicle has not been completely lost, there is still room to intervene and aim for normalization of the hair cycle. Once microscopic caliber variation becomes visible, combining scalp injection of stem cell conditioned media with standard therapies such as finasteride or minoxidil may allow a design that gently rewinds the timeline.
For overall guidance on AGA treatment, the guidelines of the Japanese Dermatological Association are a useful reference. For deeper articles on hair regenerative medicine, please also see our list of related columns on hair regenerative medicine.
Frequently Asked Questions
Q. If I act while my hair is just starting to feel finer, can it be brought back?
As long as the follicle itself has not been completely lost, there is room to intervene and aim for normalization of the hair cycle. Conversely, in scarring alopecia or areas where the follicle itself has been lost through years of neglect, current regenerative medicine cannot restore what has disappeared. Evaluating the scalp environment early is what matters.
Q. Isn’t it fine to start treatment only once the symptoms are obvious?
By the time density loss is visible to the naked eye, the shrinking process has often been progressing for years. The subtle stage of caliber variation is considered the timing when the response to treatment tends to be the strongest.
Q. Can stem cell conditioned media alone treat thinning hair?
It is not a treatment that stands alone. For AGA, finasteride, dutasteride, and minoxidil are the base therapies, and stem cell conditioned media is positioned as a supportive layer that works on the microenvironment of the dermal papilla in combination with them. A design that fits the stage of progression is required.
Q. When do you judge the effect?
Given that one hair cycle takes time, we usually compare standardized photographs and microscopic findings on hair caliber and per-follicle count at 3–6 months. Rather than judging in a few weeks, evaluation with the timeline in mind matters.
Q. If I stop, will it progress again?
As long as the underlying drivers of thinning hair (such as androgen signaling) remain, the pressure to progress remains. If treatment is discontinued, the pace of hair cycle shortening may gradually return, which is why we share a long-term design that separates an “induction phase” from a “maintenance phase” from the first visit.
──────────────
Supervising Physician: Shin Moriwaki, M.D.
Member of the Japan Society of Aesthetic Surgery (JSAS) / Member of the American Academy of Aesthetic Medicine
ECFMG certificate holder
──────────────
📍AVAN TOKYO 銀座 毛髪再生医療
AVAN TOKYO Ginza Hair Regenerative Medicine
English / 中文 / Tiếng Việt supported
Please reach out via DM / LINE / Website / Phone.